Robert Iannone - Mar 3, 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP, Global Head of Research a
Signature
By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone
Stock symbol
JAZZ
Transactions as of
Mar 3, 2023
Transactions value $
-$324,682
Form type
4
Date filed
3/7/2023, 08:22 PM
Previous filing
Dec 13, 2022
Next filing
May 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +12.4K +34.27% $0.00 48.8K Mar 3, 2023 Direct F1
transaction JAZZ Ordinary Shares Tax liability -$325K -2.27K -4.66% $142.78 46.5K Mar 5, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
F2 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.